Brazil Transcatheter Heart Valves Market Outlook to 2036 - Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Implantation (TMVI), Transcatheter Mitral Valve Repair (TMVR) and Others

1.1 What Is This Report About?
1.2 Transcatheter Heart Valves Market Segmentation
1.3 Definitions of Markets Covered in the Report

2.1 Transcatheter Heart Valves Market, United States, Revenue ($m), 2024-2036
2.1.1 Transcatheter Tricuspid Valve Repair and Replacement Market, United States, Revenue ($m), by Segment, 2024-2036
2.2 Transcatheter Heart Valves Market, United States, Volume (Units), 2024-2036
2.2.1 Transcatheter Tricuspid Valve Repair and Replacement Market, United States, Volume (Units), by Segment, 2024-2036
2.3 Transcatheter Heart Valves Market, United States, Average Price ($), 2024-2036
2.4 Transcatheter Heart Valves Market, United States, Company Share by Revenue ($m), 2025

3.1 Transcatheter Heart Valves Market Pipeline Products
3.2 Transcatheter Heart Valves - Pipeline Products by Stage of Development
3.3 Transcatheter Heart Valves - Pipeline Products by Segment
3.4 Transcatheter Heart Valves - Pipeline Products by Territory
3.5 Transcatheter Heart Valves - Pipeline Products by Regulatory Path
3.6 Transcatheter Heart Valves - Pipeline Products by Estimated Approval Date

4.1 Edwards Lifesciences Corp
4.1.1 Company Overview
4.2 Medtronic Plc
4.2.1 Company Overview
4.3 Abbott Laboratories
4.3.1 Company Overview

5.1 Corporate Communications
5.1.1 Jan 29, 2026: JenaValve Appoints John Molyneux to Vice President of Operations
5.1.2 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System
5.1.3 Oct 30, 2025: 100 Million Gift Advances UCSF’s Dementia Research and Care
5.1.4 Oct 30, 2025: Edwards Lifesciences CFO Transition Plan Announced
5.1.5 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial
5.1.6 Oct 13, 2025: Tavr And Savr Removal With Left Ventricular Outflow Reconstruction
5.1.7 Oct 08, 2025: Job Opportunity at the Adaptive Brain Lab: Research Programme Manager Position
5.1.8 Oct 07, 2025: Jupiter Endovascular Secures Over $40 Million in Series B Financing
5.1.9 Oct 01, 2025: MRC Centre Of Research Excellence Round Four Now Open Internal Deadline 21st Oct 2025
5.1.10 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
5.1.11 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
5.2 Financial Announcements
5.2.1 Feb 03, 2026: Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
5.2.2 Oct 23, 2025: Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025
5.2.3 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
5.2.4 Jul 18, 2025: Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025
5.3 Government and Public Interest
5.3.1 Nov 17, 2025: Anteris Technologies Presents Data from 100 DurAVR THV Patients at PCR London Valves
5.3.2 Nov 03, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
5.3.3 May 01, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
5.4 Other Significant Developments
5.4.1 Nov 24, 2025: JenaValve Publishes ALIGN-AR Trial Results in The Lancet and at PCR London Valves
5.4.2 Oct 16, 2025: Excision Of A Six-Year-Old Evolut CoreValve TAVR
5.4.3 Oct 13, 2025: Tavr And Savr Removal With Left Ventricular Outflow Reconstruction
5.5 Product News
5.5.1 Nov 24, 2025: JenaValve Publishes ALIGN-AR Trial Results in The Lancet and at PCR London Valves
5.5.2 Nov 17, 2025: Anteris Technologies Presents Data from 100 DurAVR THV Patients at PCR London Valves
5.5.3 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System
5.5.4 Nov 10, 2025: JenaValve's Trilogy System Featured in Live Procedure at TCT 2025
5.5.5 Oct 27, 2025: Successful Patient Outcomes With Edwards’ SAPIEN M3 and EVOQUE Systems
5.5.6 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial
5.5.7 Oct 07, 2025: Jupiter Endovascular Secures Over $40 Million in Series B Financing
5.5.8 Sep 10, 2025: JenaValve Announces ESC Guidelines Recognize TAVI for Aortic Regurgitation
5.6 Strategy And Business Planning
5.6.1 Sep 11, 2025: Penumbra, Inc. Establishes Manufacturing Plant in Costa Rica

6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the analyst Consulting
6.3 Contact the Publisher
6.4 Disclaimer

Table 1: Transcatheter Heart Valves Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 2: Transcatheter Tricuspid Valve Repair and Replacement Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 3: Transcatheter Heart Valves Market, United States, Volume (Units), 2024-2036
Table 4: Transcatheter Tricuspid Valve Repair and Replacement Market, United States, Volume (Units), 2024-2036
Table 5: Transcatheter Heart Valves Market, United States, Average Price ($), 2024-2036
Table 6: Transcatheter Heart Valves Market, United States, Company Share by Revenue ($m), USD Constant, 2025
Table 7: Transcatheter Heart Valves Market Pipeline Products
Table 8: Transcatheter Heart Valves - Pipeline Products by Stage of Development
Table 9: Transcatheter Heart Valves Companies - Pipeline Products by Stage of Development
Table 10: Transcatheter Heart Valves - Pipeline Products by Segment
Table 11: Transcatheter Heart Valves - Pipeline Products by Territory
Table 12: Transcatheter Heart Valves - Pipeline Products by Regulatory Path
Table 13: Transcatheter Heart Valves - Pipeline Products by Estimated Approval Date
Table 14: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country

Figure 1: Transcatheter Heart Valves Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 2: Transcatheter Tricuspid Valve Repair and Replacement Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 3: Transcatheter Heart Valves Market, United States, Volume (Units), 2024-2036
Figure 4: Transcatheter Tricuspid Valve Repair and Replacement Market, United States, Volume (Units), 2024-2036
Figure 5: Transcatheter Heart Valves Market, United States, Company Share (%), 2025
Figure 6: Transcatheter Heart Valves - Pipeline Products by Stage of Development
Figure 7: Transcatheter Heart Valves - Pipeline Products by Segment
Figure 8: Transcatheter Heart Valves - Pipeline Products by Territory
Figure 9: Transcatheter Heart Valves - Pipeline Products by Regulatory Path
Figure 10: Transcatheter Heart Valves - Pipeline Products by Estimated Approval Date